Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients

Completed

Conditions studied: Hypoalbuminemia

In brief

The purpose of this study is to investigate potential mechanisms of valproic acid-associated low serum albumin in medically fragile pediatric and young adult epileptic patients of a long-term care facility.

Key facts

Study ID

NCT00723762

Run by

Akron Children's Hospital

People needed

90

Starts

2009-02-01

Expected to finish

2010-12-01

Last updated by the study team

2011-03-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Resident of Hattie Larlham long-term care facility receiving VPA for > 3 months at the start of the study
• Resident of Hattie Larlham long-term care facility matched to a resident receiving VPA for > 3 month based on concomitant AED, length of time on AED, age, and gender
• Resident of Hattie Larlham long-term care facility not receiving AED matched to a resident receiving VPA for > 3 month based on age and gender

You may not qualify if…

• Received albumin products within the past 1 month
• Receiving VPA for < 3 months or discontinuation of VPA therapy within the past four weeks
• Medical need for specific protein supplementation
• Diagnosed with protein-losing nephropathy or enteropathy

Where it is running

• Hattie Larlham Center for Children with Disabilities — Mantua, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.